Related Experiment Video
Updated: Jan 30, 2026

Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
Published on: November 26, 2018
A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell
Allison M L Nixon1,2, Alejandro Duque1, Nicholas Yelle3,4
1Donnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Abstract:
Cell surface antigen discovery is of great interest for biomedical research both for isolation of rare cell populations and therapeutic targeting. We developed a rapid, cost-effective, fully in vitro technology which facilities the simultaneous target discovery and human antibody generation on the surface of virtually any cell population of interest. We apply our technique to human colorectal cancer-initiating cells (CICs) and identify hundreds of unique human antibodies. We characterized the top three antibody candidates targeting these CICs and identify their protein targets as integrin α7 (ITGA7), HLA-A1 and integrin β6 (ITGB6). We demonstrate that these antibodies can be used to isolate self-renewing colorectal CICs, and that the integrin α7 antibody can prospectively identify glioblastoma brain tumor initiating cells as well as human muscle stem cells. We also demonstrate that genetic ablation of integrin β6 impedes colorectal CIC function. The methodology can be readily applied to other cell populations including stem cells, cancer, or immune cells to facilitate the rapid identification of novel targets and simultaneous generation of potent and specific antibodies with therapeutic potential.
Insights
Researchers developed a novel in vitro method for discovering cell surface targets and generating human antibodies simultaneously. This technique successfully identified new targets on colorectal cancer-initiating cells (CICs), enabling their isolation and potential therapeutic strategies.
Area of Science:
- Biomedical Research
- Immunology
- Oncology
Background:
- Cell surface antigen discovery is crucial for isolating rare cells and developing targeted therapies.
- Existing methods for antibody generation can be time-consuming and costly.
Purpose of the Study:
- To develop a rapid, cost-effective, in vitro technology for simultaneous cell surface target discovery and human antibody generation.
- To apply this technology to human colorectal cancer-initiating cells (CICs) and identify novel therapeutic targets.
Main Methods:
- A novel in vitro technology was employed for simultaneous target discovery and antibody generation.
- The technique was applied to human colorectal cancer-initiating cells (CICs).
- Antibody candidates were characterized, and their protein targets were identified.
Main Results:
- Hundreds of unique human antibodies were identified against colorectal CICs.
- Top antibody candidates targeted integrin α7 (ITGA7), HLA-A1, and integrin β6 (ITGB6).
- The ITGA7 antibody successfully isolated colorectal CICs and identified glioblastoma and muscle stem cells; ITGB6 ablation impaired CIC function.
Conclusions:
- The developed methodology enables rapid identification of novel cell surface targets and generation of specific antibodies.
- This approach has broad applicability for stem cells, cancer cells, and immune cells, facilitating therapeutic development.
- The identified targets (ITGA7, HLA-A1, ITGB6) offer potential for isolating and targeting specific cell populations, including cancer-initiating cells.
Related Concept Videos
Drug Discovery: Overview
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
In-vitro Mutagenesis
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Response Surface Methodology
The process of RSM involves several key steps:
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

